Jeffrey Purvin

Mr. Purvin has spent his career in medical device companies and has raised +$100 Million in venture capital and public funding in Silicon Valley California, Vancouver Canada, and New York City. Most recently Mr. Purvin was the CEO at Response Biomedical (TSX: RBM, OTCQB: RPBIF). Prior to joining Response Biomedical, Mr. Purvin was the Founder and CEO of Calibra Medical, Inc which was acquired by Johnson & Johnson in 2012. Prior to Calibra, Mr. Purvin was Chairman and CEO of Metrika, Inc who developed a handheld, point-of-care, HbA1c test. Metrika was acquired by Bayer in 2006.